{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:25:17Z","timestamp":1777616717072,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.vaccine.2008.06.102","type":"journal-article","created":{"date-parts":[[2008,7,25]],"date-time":"2008-07-25T08:41:27Z","timestamp":1216975287000},"page":"4813-4818","source":"Crossref","is-referenced-by-count":28,"title":["Induction of Th1-type cellular responses in cured\/exposed Leishmania-infected patients and hamsters against polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1kDa"],"prefix":"10.1016","volume":"26","author":[{"given":"Shraddha","family":"Kumari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukesh","family":"Samant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant","family":"Khare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhir","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Dube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.vaccine.2008.06.102_bib1","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda","volume":"2","author":"Guerin","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2008.06.102_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2008.06.102_bib3","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1084\/jem.185.5.867","article-title":"Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model","volume":"185","author":"Murray","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.06.102_bib4","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1016\/j.vaccine.2007.05.042","article-title":"Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response","volume":"25","author":"Bhowmick","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.102_bib5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0952-7915(93)90033-O","article-title":"T-cell and cytokine responses in leishmaniasis","volume":"5","author":"Reed","year":"1993","journal-title":"Curr Opin Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.06.102_bib6","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.4049\/jimmunol.161.11.6171","article-title":"LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile","volume":"161","author":"Skeiky","year":"1998","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2008.06.102_bib7","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/IAI.70.8.4215-4225.2002","article-title":"Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis","volume":"70","author":"Coler","year":"2002","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.102_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2249.2005.02745.x","article-title":"Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani","volume":"140","author":"Garg","year":"2005","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.102_bib9","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI116341","article-title":"Cytokine patterns in the pathogenesis of human leishmaniasis","volume":"91","author":"Pirmez","year":"1993","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.vaccine.2008.06.102_bib10","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.4049\/jimmunol.151.7.3712","article-title":"Antigen-reactive gamma delta T cells in human leishmaniasis","volume":"151","author":"Russo","year":"1993","journal-title":"J Immunol"},{"issue":"15","key":"10.1016\/j.vaccine.2008.06.102_bib11","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.vaccine.2005.12.053","article-title":"Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis","volume":"24","author":"Garg","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.102_bib12","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00436-005-1339-1","article-title":"Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models","volume":"96","author":"Dube","year":"2005","journal-title":"Parasitol Res"},{"issue":"5","key":"10.1016\/j.vaccine.2008.06.102_bib13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/pmic.200600725","article-title":"Proteomic approach for identification and characterization of novel immunostimulatory proteins from soluble antigens of Leishmania donovani promastigotes","volume":"7","author":"Gupta","year":"2007","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.102_bib14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.vaccine.2008.06.102_bib15","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4269\/ajtmh.1997.56.522","article-title":"Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis","volume":"56","author":"Sundar","year":"1997","journal-title":"Am J Trop Med Hyg"},{"issue":"5259","key":"10.1016\/j.vaccine.2008.06.102_bib16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.102_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0003-2697(81)90179-2","article-title":"Silver staining of proteins in polyacrylamide gels","volume":"118","author":"Wray","year":"1981","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2008.06.102_bib18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0003-2697(84)90782-6","article-title":"A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids","volume":"138","author":"Wessel","year":"1984","journal-title":"Anal Biochem"},{"key":"10.1016\/j.vaccine.2008.06.102_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0003-2697(92)90502-X","article-title":"Colorimetric quantitation of trace amounts of sodium lauryl sulfate in the presence of nucleic acids and proteins","volume":"207","author":"Arand","year":"1992","journal-title":"Anal Biochem"},{"issue":"7","key":"10.1016\/j.vaccine.2008.06.102_bib20","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.141.7.2407","article-title":"Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production","volume":"141","author":"Ding","year":"1988","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.102_bib21","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/eji.1830240328","article-title":"Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major","volume":"24","author":"Assreuy","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2008.06.102_bib22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.15.1.323","article-title":"Nitric oxide and macrophage function","volume":"15","author":"MacMicking","year":"1997","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.06.102_bib23","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2008.06.102_bib24","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.4049\/jimmunol.147.10.3575","article-title":"Human T cell responses to gp63, a surface antigen of Leishmania","volume":"147","author":"Russo","year":"1991","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.102_bib25","doi-asserted-by":"crossref","first-page":"742","DOI":"10.4049\/jimmunol.146.2.742","article-title":"Characterization of a membrane antigen of Leishmania amazonensis that stimulates human immune responses","volume":"146","author":"Burns","year":"1991","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.06.102_bib26","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.4049\/jimmunol.174.11.7160","volume":"174","author":"Basu","year":"2005","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.102_bib27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2249.2005.03000.x","article-title":"Identification of Leishmania donovani antigens stimulating cellular immune responses in exposed immune individuals","volume":"143","author":"Tripathi","year":"2006","journal-title":"Clin Exp Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08008633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08008633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T09:48:29Z","timestamp":1684489709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08008633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":27,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0264410X08008633"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.06.102","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}